Chem Path 2 - Lipid metabolism Flashcards

1
Q

What are the features of an atherosclerotic lesion?

A

Fibrous cap

Foam cells (macrophages full of cholesteryl ester)

Necrotic core (full of cholesterol crystals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the biggest plasma lipoprotein?

A

Chylomicrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

During what time will chylomicrons be most abundant?

A

After eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the uptake of cholesterol by the intestinal epithelium.

A

Cholesterol entering the intestines will come from the diet and bile

Cholesterol will be solubilised in mixed micelles

It is then transported across the intestinal epithelium by NPC1L1 (this is the main determinant of cholesterol transport)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name two transporters that transport cholesterol back into the intestinal lumen.

A

ABC G5

ABC G8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are bile acids absorbed?

A

Terminal ileum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens when cholesterol arrives at the liver?

A

Downregulates the activity of HMG CoA reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two fates of cholesterol that is either produced by or transported to the liver?

A

Hydroxylation by 7a-hydroxylase to produce bile acids

Esterification by ACAT to produce cholesterol ester which is incorporated into VLDLs along with triglycerides and ApoB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which transfer protein is important in the packaging of VLDLs?

A

MTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which transfer protein is important in the packaging of HDLs?

A

ABC A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the effects of CETP on the movement of substances between lipoproteins?

A

Moves cholesterol from HDL to VLDL

Moves triglycerides from VLDL to HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which receptor is responsible for the uptake of some HDLs by the liver?

A

SR-B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the transport and metabolism of triglycerides

A

Triglycerides from fatty foods are hydrolysed to fatty acids, absorbed, and resynthesized into triglycerides which are transported by chylomicrons into the plasma

Chylomicrons are hydrolysed by lipoprotein lipase into free fatty acids

Some free fatty acids are taken up by the liver, and some by adipose tissue

The liver resynthesizes fatty acids into triglycerides and packages them into VLDLs

VLDLs are acted upon by lipoprotein lipase to liberate free fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the three causes of familial hypercholesterolaemia (type II)

A

Caused by autosomal dominant gene mutations in:

LDL receptor

ApoB

PCSK9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List some mutations that are implicated in polygenic hypercholesterolaemia.

A

NPC1L1

HMGCR

CYP7A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is familial hyperalphalipoproteinaemia?

A

Increase in HDL caused by deficiency of CETP

This is associated with longevity

17
Q

What is phytosterolaemia?

A

Increased plasma concentrations of plant sterols due to mutations in ABC G5 and ABC G8

NOTE: this condition is associated with premature atherosclerosis

18
Q

Describe the function of the LDL receptor.

A

LDLs bind to LDLR in coated pits which then undergo endocytosis (thereby uptaking the LDL into the liver)

19
Q

List some clinical features of familial hypercholesterolaemia.

A

Xanthelasma

Corneal arcus

Tendon xanthomata

20
Q

What is PCSK9?

A

A protein that binds to LDL receptors and degrades them

NOTE: gain of function mutations result in increased breakdown of LDLR and hence increased plasma LDL levels

21
Q

List the key features of Familial Type I hypertriglyceridaemia

A

Caused by deficiency of lipoprotein lipase and ApoC II

NOTE: lipoprotein lipase degrades chylomicrons and ApoC II is an activator of lipoprotein lipase

22
Q

List the key features of Familial Type IV hypertriglyceridaemia

A

Characterised by increased synthesis of triglycerides

23
Q

List the key features of Familial Type V hypertriglyceridaemia

A

Characterised by deficiency of ApoA V

24
Q

What is familial combined hyperlipidaemia?

A

Some people in the family have high cholesterol and others have high triglycerides

25
Q

What is familial dysbetalipoproteinaemia (type III)?

A

Due to aberrant form of ApoE (E2/2)

NOTE: normal form is ApoE (3/3)

A diagnostic clinical feature of yellowing of the palmar crease (palmar striae)

26
Q

List some causes of secondary hyperlipidaemia.

A

Pregnancy

Hypothyroidism

Obesity

Nephrotic syndrome

27
Q

List four causes of hypolipidaemia and their underlying genetic defect.

A

Ab-lipoproteinaemia

· Autosomal recessive

· Extremely low levels of cholesterol

· Due to deficiency of MTP

Hypob-lipoproteinaemia

· Autosomal dominant

· Low LDL

· Caused by mutations in ApoB

Tangier disease

· Low HDL

· Caused by mutation of ABC A1

Hypoa-lipoproteinaemia

· Sometimes caused by mutation of ApoA1

28
Q

Describe the role of LDL in atherosclerosis.

A

LDL becomes oxidised once it has got through the vascular endothelium

Once oxidised it is taken up by macrophages

Within the macrophages, the LDLs become esterified and you develop foam cells

29
Q

List some lipid-lowering drugs and their effect on lipid levels.

A

Statins – reduce LDLs, increase HDLs, slight increase in triglycerides

Fibrates – lower triglycerides, little effects on LDL/HDL

Ezetimibe – reduces cholesterol absorption (blocks NPC1L1)

Colestyramine – resin that binds to bile acids and reduces their absorption

30
Q

List some novel forms of lipid-lowering drugs.

A

Lomitapide – MTP blocker

REGN727 – anti-PCSK9 monoclonal antibody

Mipomersen – anti-sense ApoB oligonucleotide

31
Q

List three types of bariatric surgery.

A

Gastric banding

Roux-en-Y gastric bypass

Biliopancreatic diversion

32
Q

What is the definition of success in bariatric surgery?

A

More than 50% reduction in excess weight

33
Q

List some beneficial effects of bariatric surgery.

A

Reduced diabetes risk

Reduced serum triglycerides

Increased HDLs

Reduced fatty liver

Reduced blood pressure